LivaNova EV/EBIT LIVN

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2017.

Today, Oct 23, 2026: 22.6×
9-year median: 47.2×
Against its 9-year history: 33rd; percentile: 0 is its lowest day, 100 its highest
9-year range: 13.0× to 442×
Peer median: 23.4×

LivaNova's EV/EBIT is 22.6× as of Oct 23, 2026.

That is below its 9-year median of 47.2×, lower than on 67% of days in the last 9 years.

Over that time it ranged from 13.0× in Mar 2020 to 442× in Nov 2019.

The median for 6 medical device stocks of a similar size is 23.4×.

EV/EBIT over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	22.6×	14.7×	23.0×
2025	16.6×	13.1×	255×
2024	239×	51.5×	267×
2023	54.3×	46.1×	93.8×
2022	51.8×	32.8×	277×
2021	28.8×	23.9×	28.8×
2020	25.0×	13.0×	390×
2019	400×	72.0×	442×
2018	73.1×	34.9×	103×
2017	38.8×	38.4×	42.6×

Against its peers

Companies in Medical - Devices nearest LivaNova's size, closest first, today.

Company	EV/EBIT
LIVNLivaNova	22.6×
ITGRInteger	29.7×
TMDXTransMedics	34.7×
CNMDCONMED	20.6×
ZBHZimmer Biomet	21.5×
DXCMDexCom	25.3×
GEHCGE HealthCare Technologies	14.7×
Peer median	23.4×

Where LivaNova ranks

#7of 13Medical device stocks with the lowest EV/EBIT

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on LivaNova

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.